3136 results for «945»

Filter By

3136 results

Challenging vascular access and closure management

21 May 2025 – From EuroPCR 2025

Address challenging vascular access and closure management in complex TAVI cases. This session covers the selection of femoral access, use of PTA and intravascular lithotripsy, and strategies to manage closure failure with illustrative real-world cases.

Challenging vascular access and closure management

Imaging coronary artery disease – New frontiers

21 May 2025 – From EuroPCR 2025

Delve into new frontiers in imaging coronary artery disease, shifting focus from ischemia to plaque characteristics for revascularisation decisions. This session highlights the pivotal role of intracoronary imaging in understanding complex vessel anatomy and planning treatment, illustrated through detailed case studies showcasing unusual anatomies requiring tailored...

Imaging coronary artery disease – New frontiers

DCB after REC-CAGEFREE 1 - Vulnerable plaque PCI after PREVENT

21 May 2025 – From EuroPCR 2025

Reflect on the impact of recent trials REC-CAGEFREE 1 and PREVENT on the use of drug-coated balloons (DCB) and preventive PCI for vulnerable plaque. This session includes case discussions highlighting DCB applications and insights from cutting-edge clinical studies.

DCB after REC-CAGEFREE 1 - Vulnerable plaque PCI after PREVENT

ACS with normal coronary arteries: angiography done, job done?

21 May 2025 – From EuroPCR 2025

Understand the clinical significance of MINOCA and learn diagnostic strategies integrating invasive and non-invasive tests to identify underlying etiologies. This session provides therapeutic insights tailored to specific MINOCA endotypes through illustrative cases.

ACS with normal coronary arteries: angiography done, job done?

TAVI in challenging cases: pushing the limits

21 May 2025 – From EuroPCR 2025

Navigate challenging TAVI cases with this focused session emphasizing valve-in-valve procedures in complex anatomical scenarios. Learn strategies for managing TAVI in patients with multivessel disease and impaired ventricular function, and optimize procedural planning using advanced imaging, access methods, and device selection through detailed case presentations and...

TAVI in challenging cases: pushing the limits

Optimising CTO outcomes by lesion selection

21 May 2025 – From EuroPCR 2025

Optimize chronic total occlusion (CTO) PCI outcomes through lesion selection strategies. This session reviews coronary calcium patterns via CT, target vessel considerations, distal vessel remodeling, imaging-guided versus conventional approaches, and complex lesion cases.

Optimising CTO outcomes by lesion selection

Novel tools and strategies in chronic heart failure

21 May 2025 – From EuroPCR 2025

Discover novel tools and therapeutic strategies in chronic heart failure management. This session presents early clinical experiences with innovative devices such as a chronically-adjustable pressure sensing interatrial shunt, synchronized diaphragmatic stimulation, high-flow pLVADs for cardiogenic shock, and renal artery denervation. Additionally, it reviews the impact of...

Novel tools and strategies in chronic heart failure

Hotline TAVI 2: outcomes with new and established devices

21 May 2025 – From EuroPCR 2025

Review outcomes of new and established TAVI devices through pooled analyses and multicenter studies. Topics include comparisons of balloon-expandable valves, intra- versus supra-annular self-expanding valves, and insights from the ACURATE IDE and ACURATE prime studies.

Hotline TAVI 2: outcomes with new and established devices

Multi-modality assessment of coronary disease

21 May 2025 – From EuroPCR 2025

This session offers comprehensive multi-modality assessment of coronary disease, integrating advanced imaging and functional testing. Topics include diagnostic yield of OCT and cardiac MRI for MINOCA, transitioning coronary plaque vulnerability assessment from invasive to non-invasive methods, relationships between QFR and IVUS post-PCI in complex lesions, combined...

Multi-modality assessment of coronary disease

New tools for left main treatment

21 May 2025 – From EuroPCR 2025

Examine new tools and strategies tailored for left main coronary artery treatment. This session covers real-world data on intracoronary imaging guidance, post-PCI FFR assessment following provisional T stenting, safety and efficacy of intravascular lithotripsy for calcified left main disease, drug-coated balloon (DCB) treatments for true bifurcation...

New tools for left main treatment

How to select appropriate cardiovascular intervention for a patient with tricuspid regurgitation?

21 May 2025 – From EuroPCR 2025

Learn how to select appropriate cardiovascular interventions for tricuspid regurgitation patients by considering comorbidities, anatomical factors influencing procedural success, and imaging criteria for device selection. The session includes patient vignettes to illustrate decision-making pathways.

How to select appropriate cardiovascular intervention for a patient with tricuspid regurgitation?

TAVI for aortic regurgitation: on-label and off-label use

21 May 2025 – From EuroPCR 2025

This session reviews on-label and off-label applications of transcatheter aortic valve implantation (TAVI) for treating aortic regurgitation. Examine complex cases including TAVI in patients with aortic dissection, cardiogenic shock, and valve-in-valve interventions, highlighting innovative procedural approaches and bailout strategies.

TAVI for aortic regurgitation: on-label and off-label use

Unconventional situations and complications during cardiovascular interventions

21 May 2025 – From EuroPCR 2025

Explore this session to gain expert tips and practical strategies for managing unexpected complications during cardiovascular interventions. Learn how to anticipate and avoid complications in conventional procedures and discover different approaches to tackle challenging situations in the cathlab through detailed case discussions involving PCI, TAVI, and...

Unconventional situations and complications during cardiovascular interventions

Cathlab harmony: building high-performance teams

21 May 2025 – From EuroPCR 2025

Discover strategies to build and maintain high-performance teams in the cathlab environment. This session outlines how to foster a collaborative culture, address toxic behaviors, and effectively train and integrate team members to enhance teamwork and procedural success in cardiovascular interventions.

Cathlab harmony: building high-performance teams

Management of high-risk left main lesion

21 May 2025 – From EuroPCR 2025

Focus on managing high-risk left main coronary lesions with this session featuring complex cases such as thrombotic lesions, calcified distal left main PCI with orbital atherectomy and IVUS guidance, and advanced stenting techniques. Learn practical approaches for challenging anatomical and clinical scenarios to optimize patient outcomes.

Management of high-risk left main lesion

DES and bioadaptator technologies in contemporary practice

21 May 2025 – From EuroPCR 2025

Delve into contemporary practice with this session on drug-eluting stents (DES) and bioadaptator technologies. Gain insights from international studies on complex PCI outcomes, comparative data from randomized trials, and real-world experiences focusing on high bleeding risk patients and elderly cohorts treated with ultrathin strut and new-generation...

DES and bioadaptator technologies in contemporary practice

Did danger shock change my practice?

21 May 2025 – From EuroPCR 2025

Reflect on how contemporary management of cardiogenic shock has evolved through this session. Review collaborative strategies, challenging clinical cases involving STEMI, multivessel disease, refractory shock, spontaneous coronary artery dissection, and the critical role of intracoronary imaging in guiding interventional decisions.

Did danger shock change my practice?

Management of non-culprit lesions in patients with ACS and multivessel disease

21 May 2025 – From EuroPCR 2025

This session addresses the optimal management of non-culprit lesions (NCL) in patients with acute coronary syndrome (ACS) and multivessel disease. Learn about angiography, imaging, and FFR-guided strategies, timing considerations for PCI in high-risk NSTEMI patients, and patient selection for early staged PCI post-STEMI through detailed case...

Management of non-culprit lesions in patients with ACS and multivessel disease

Strategies in treating double CTO scenarios

21 May 2025 – From EuroPCR 2025

Navigate complex double chronic total occlusion (CTO) scenarios with this session that emphasizes thorough lesion qualification and innovative techniques. Learn strategies including management of ambiguous proximal caps, sequential vessel revascularization, and advanced tools like snaring and deflection to optimize procedural success.

Strategies in treating double CTO scenarios

TAVI for aortic regurgitation: off-label use

21 May 2025 – From EuroPCR 2025

Explore the complexities and off-label challenges of transcatheter aortic valve implantation (TAVI) in patients with severe pure aortic regurgitation. This session highlights the bold strategies, complication management, and innovative use of the Octacor valve in this demanding clinical scenario, providing valuable insights into navigating a difficult...

TAVI for aortic regurgitation: off-label use
Didn’t find what you were looking for?